Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection

Antiviral Research

Volumn 105, Issue 1, 2014, Pages 135-142

  Hsi, Edward ^a,b   Huang, Chung Feng ^b,c   Dai, Chia Yen ^a,b   Juo, Suh Hang Hank ^a,b   Chou, Wen Wen ^b   Huang, Jee Fu ^a,d   Yeh, Ming Lun ^b   Lin, Zu Yau ^a,b   Chen, Shinn Cherng ^a,b   Wang, Liang Yen ^a,b   Chuang, Wan Long ^a,b   Yu, Ming Lung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

HCV; IL28B; MicroRNA; miR 125b; PBMC; SVR

Indexed keywords

INTERLEUKIN 28B; MICRORNA 125B; PEGINTERFERON ALPHA; RIBAVIRIN; PEGINTERFERON; ALPHA INTERFERON; ANTIVIRUS AGENT; BIOLOGICAL MARKER; MICRORNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 1 INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT OUTCOME; VIRUS LOAD; CLASSIFICATION; GENE EXPRESSION PROFILING; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGY; MONONUCLEAR CELL; PATHOLOGY; PROSPECTIVE STUDY; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RIBAVIRIN; TREATMENT OUTCOME;

EID: 84897433432     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.03.003     Document Type: Article

References (53)

1. EASL Clinical, 2011. Practice Guidelines: management of hepatitis C virus infection. J. Hepatol. 55, 245-264.
2. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355 (Pubitemid 39265675)
3. S. Bala, Y. Tilahun, O. Taha, H. Alao, K. Kodys, D. Catalano, and G. Szabo Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection J. Transl. Med. 10 2012 151
4. A.S.T. Barritt, and M.W. Fried Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus Gastroenterology 142 2012 1314 1323 e1311
5. A. Budhu, H.L. Jia, M. Forgues, C.G. Liu, D. Goldstein, A. Lam, K.A. Zanetti, Q.H. Ye, L.X. Qin, C.M. Croce, Z.Y. Tang, and X.W. Wang Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907 (Pubitemid 351449681)
6. F. Christodoulou, F. Raible, R. Tomer, O. Simakov, K. Trachana, S. Klaus, H. Snyman, G.J. Hannon, P. Bork, and D. Arendt Ancient animal microRNAs and the evolution of tissue identity Nature 463 2010 1084 1088
7. M.W. Fried, S.J. Hadziyannis, M.L. Shiffman, D. Messinger, and S. Zeuzem Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection J. Hepatol. 55 2011 69 75
8. M. Garofalo, G. Condorelli, and C.M. Croce MicroRNAs in diseases and drug response Curr. Opin. Pharmacol. 8 2008 661 667
9. D. Ge, J. Fellay, A. Thompson, J. Simon, K. Shianna, T. Urban, E. Heinzen, P. Qiu, A. Bertelsen, A. Muir, M. Sulkowski, J. McHutchison, and D. Goldstein Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 800
10. M.G. Ghany, D.R. Nelson, D.B. Strader, D.L. Thomas, and L.B. Seeff American Association for Study of Liver. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 2011 1433 1444
11. M.G. Ghany, D.B. Strader, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
12. M. Grek, A. Piekarska, J. Bartkowiak, W. Fendler, J. Kuydowicz, P. Wroblewski, M. Paradowski, and M. Sidorkiewicz Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells Int. J. Mol. Med. 28 2011 875 880
13. C.F. Huang, J.F. Huang, J.F. Yang, M.Y. Hsieh, Z.Y. Lin, S.C. Chen, L.Y. Wang, S.H. Juo, K.C. Chen, W.L. Chuang, H.T. Kuo, C.Y. Dai, and M.L. Yu Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin J. Hepatol. 56 2012 34 40
14. C.F. Huang, M.L. Yeh, J.F. Huang, J.F. Yang, M.Y. Hsieh, Z.Y. Lin, S.C. Chen, L.Y. Wang, E. Hsi, S.H. Juo, C.Y. Dai, W.L. Chuang, and M.L. Yu Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1 Antiviral Res. 93 2012 239 244
15. H.C. Huang, H.R. Yu, L.T. Huang, H.C. Huang, R.F. Chen, I.C. Lin, C.Y. Ou, T.Y. Hsu, and K.D. Yang MiRNA-125b regulates TNF-alpha production in CD14+ neonatal monocytes via post-transcriptional regulation J. Leukocyte Biol. 92 2012 171 182
16. Y. Huang, H. Yang, B.B. Borg, X. Su, S.L. Rhodes, K. Yang, X. Tong, G. Tang, C.D. Howell, H.R. Rosen, C.L. Thio, D.L. Thomas, H.J. Alter, R.K. Sapp, and T.J. Liang A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection Proc. Natl. Acad. Sci. USA 104 2007 985 990 (Pubitemid 46154723)
17. H.L. Janssen, H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A.J. van der Meer, A.K. Patick, A. Chen, Y. Zhou, R. Persson, B.D. King, S. Kauppinen, A.A. Levin, and M.R. Hodges Treatment of HCV infection by targeting microRNA New Engl. J. Med. 368 2013 1685 1694
18. C. Ji, Q. Deng, and N. Kaplowitz Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury Hepatology 40 2004 442 451 (Pubitemid 39062862)
19. J. Jiang, Y. Gusev, I. Aderca, T.A. Mettler, D.M. Nagorney, D.J. Brackett, L.R. Roberts, and T.D. Schmittgen Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival Clin. Cancer Res. 14 2008 419 427 (Pubitemid 351226109)
20. C.L. Jopling, M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 2005 1577 1581 (Pubitemid 41266486)
21. W.P. Kloosterman, and R.H. Plasterk The diverse functions of microRNAs in animal development and disease Dev. Cell 11 2006 441 450 (Pubitemid 44430905)
22. S. Komagata, M. Nakajima, S. Takagi, T. Mohri, T. Taniya, and T. Yokoi Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b Mol. Pharmacol. 76 2009 702 709
23. M.J. Koziel The role of immune responses in the pathogenesis of hepatitis C virus infection J. Viral Hepat. 4 Suppl 2 1997 31 41
24. S.M. Martinez, G. Fernandez-Varo, P. Gonzalez, E. Sampson, M. Bruguera, M. Navasa, W. Jimenez, J.M. Sanchez-Tapias, and X. Forns Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C Aliment. Pharmacol. Ther. 33 2011 138 148
25. J.G. McHutchison, M. Manns, K. Patel, T. Poynard, K.L. Lindsay, C. Trepo, J. Dienstag, W.M. Lee, C. Mak, J.J. Garaud, and J.K. Albrecht Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C Gastroenterology 123 2002 1061 1069
26. T. Mohri, M. Nakajima, S. Takagi, S. Komagata, and T. Yokoi MicroRNA regulates human vitamin D receptor Int. J. Cancer 125 2009 1328 1333
27. A.J. Murphy, P.M. Guyre, and P.A. Pioli Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages J. Immunol. 184 2010 5029 5037
28. A. Nasir, H.S. Arora, and H.E. Kaiser Apoptosis and pathogenesis of viral hepatitis C-an update In Vivo 14 2000 297 300 (Pubitemid 30189241)
29. M. Omata, T. Kanda, M.L. Yu, O. Yokosuka, S.G. Lim, W. Jafri, R. Tateishi, S.S. Hamid, W.L. Chuang, A. Chutaputti, L. Wei, J. Sollano, S.K. Sarin, J.H. Kao, and G.W. McCaughan APASL consensus statements and management algorithms for hepatitis C virus infection Hepat. Int. 6 2012 409 435
30. D. Otaegui, S.E. Baranzini, R. Armananzas, B. Calvo, M. Munoz-Culla, P. Khankhanian, I. Inza, J.A. Lozano, T. Castillo-Trivino, A. Asensio, J. Olaskoaga, and A. Lopez de Munain Differential micro RNA expression in PBMC from multiple sclerosis patients PLoS One 4 2009 e6309
31. B.L. Pearlman, and C. Ehleben Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor Hepatology 2013
32. R.L. Rossi, G. Rossetti, L. Wenandy, S. Curti, A. Ripamonti, R.J. Bonnal, R.S. Birolo, M. Moro, M.C. Crosti, P. Gruarin, S. Maglie, F. Marabita, D. Mascheroni, V. Parente, M. Comelli, E. Trabucchi, R. De Francesco, J. Geginat, S. Abrignani, and M. Pagani Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b Nat. Immunol. 12 2011 796 803
33. J.L. Rukov, and N. Shomron MicroRNA pharmacogenomics: post-transcriptional regulation of drug response Trends Mol. Med. 17 2011 412 423
34. M. Sarasin-Filipowicz, J. Krol, I. Markiewicz, M.H. Heim, and W. Filipowicz Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy Nat. Med. 15 2009 31 33
35. R.S. Tacke, A. Tosello-Trampont, V. Nguyen, D.W. Mullins, and Y.S. Hahn Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway J. Biol. Chem. 286 2011 10847 10855
36. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige, Y. Ito, E. Mita, E. Tanaka, S. Mochida, Y. Murawaki, M. Honda, A. Sakai, Y. Hiasa, S. Nishiguchi, A. Koike, I. Sakaida, M. Imamura, K. Ito, K. Yano, N. Masaki, F. Sugauchi, N. Izumi, K. Tokunaga, and M. Mizokami Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat. Genet. 41 2009 1105 1109
37. E. Tili, J.J. Michaille, A. Cimino, S. Costinean, C.D. Dumitru, B. Adair, M. Fabbri, H. Alder, C.G. Liu, G.A. Calin, and C.M. Croce Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock J. Immunol. 179 2007 5082 5089
38. T. Tonan, K. Fujimoto, A. Qayyum, Y. Morita, O. Nakashima, N. Ono, A. Kawahara, M. Kage, N. Hayabuchi, and T. Ueno CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation J. Gastroenterol. Hepatol. 27 2012 789 796
39. S. Ura, M. Honda, T. Yamashita, T. Ueda, H. Takatori, R. Nishino, H. Sunakozaka, Y. Sakai, K. Horimoto, and S. Kaneko Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma Hepatology 49 2009 1098 1112
40. J. Vermehren, M.L. Yu, A. Monto, J.D. Yao, C. Anderson, R. Bertuzis, G. Schneider, and C. Sarrazin Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C J. Clin. Virol. 52 2011 133 137
41. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram, and A.S. Lok A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526 (Pubitemid 36919874)
42. C. Wei, J. Li, and R.E. Bumgarner Sample size for detecting differentially expressed genes in microarray experiments BMC Genomics 5 2004 87
43. Y. Xiong, J.H. Fang, J.P. Yun, J. Yang, Y. Zhang, W.H. Jia, and S.M. Zhuang Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma Hepatology 51 2010 836 845
44. J.F. Yang, Y.Y. Lin, M.H. Hsieh, C.H. Tsai, S.F. Liu, M.L. Yu, C.Y. Dai, J.F. Huang, W.Y. Lin, Z.Y. Lin, S.C. Chen, and W.L. Chuang Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups Kaohsiung J. Med. Sci. 27 2011 258 263
45. J. Yao, L. Liang, S. Huang, J. Ding, N. Tan, Y. Zhao, M. Yan, C. Ge, Z. Zhang, T. Chen, D. Wan, M. Yao, J. Li, J. Gu, and X. He MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma Hepatology 51 2010 846 856
46. M.L. Yu, and W.L. Chuang Treatment of chronic hepatitis C in Asia: when east meets west J. Gastroenterol. Hepatol. 24 2009 336 345
47. M.L. Yu, C.Y. Dai, J.F. Huang, C.F. Chiu, Y.H. Yang, N.J. Hou, L.P. Lee, M.Y. Hsieh, Z.Y. Lin, S.C. Chen, L.Y. Wang, W.Y. Chang, and W.L. Chuang Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial Hepatology 47 2008 1884 1893
48. M.L. Yu, C.Y. Dai, J.F. Huang, N.J. Hou, L.P. Lee, M.Y. Hsieh, C.F. Chiu, Z.Y. Lin, S.C. Chen, L.Y. Wang, W.Y. Chang, and W.L. Chuang A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C Gut 56 2007 553 559
49. M.L. Yu, C.F. Huang, J.F. Huang, N.C. Chang, J.F. Yang, Z.Y. Lin, S.C. Chen, M.Y. Hsieh, L.Y. Wang, W.Y. Chang, Y.N. Li, M.S. Wu, C.Y. Dai, S.H. Juo, and W.L. Chuang Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients Hepatology 53 2011 7 13
50. M.L. Yu, C.M. Lee, C.L. Chen, W.L. Chuang, S.N. Lu, C.H. Liu, S.S. Wu, L.Y. Liao, H.T. Kuo, Y.C. Chao, S.Y. Tung, S.S. Yang, J.H. Kao, W.W. Su, C.L. Lin, H.C. Yang, P.J. Chen, D.S. Chen, C.J. Liu, and C. Taiwan Liver-Net Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up Hepatology 57 2013 2135 2142
51. M.L. Yu, S.M. Lin, C.M. Lee, C.Y. Dai, W.Y. Chang, S.C. Chen, L.P. Lee, Z.Y. Lin, M.Y. Hsieh, L.Y. Wang, W.L. Chuang, and Y.F. Liaw A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy Hepatology 44 2006 1086 1097
52. H. Zhang, X.Q. Luo, D.D. Feng, X.J. Zhang, J. Wu, Y.S. Zheng, X. Chen, L. Xu, and Y.Q. Chen Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia Mol. Cancer 10 2011 108
53. Y. Zhang, W. Wei, N. Cheng, K. Wang, B. Li, X. Jiang, and S. Sun Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling Hepatology 56 2012 1631 1640